18 min listen
Improving Drug Development through Better Use of Biomarkers
FromThe Bio Report
ratings:
Length:
24 minutes
Released:
Jul 21, 2016
Format:
Podcast episode
Description
The use of biomarkers has long held the promise accelerating drug development and producing safer and more targeted drugs to meet the needs of patients. The explosion of genetic, proteomic, and metabolomic data, as well as the emergence of the human microbiome, is rapidly growing the world of biomarkers, but with that comes challenges for researchers and drug developers about knowing what’s available and how well validated these biomarkers may be. We spoke to John Audette, president and co-founder of Amplion, about the company’s database, which seeks to make biomarker information accessible to researchers, the role biomarkers can play in improving the drug development process, and how their increased use can bring about a long anticipated era of precision medicine.
Released:
Jul 21, 2016
Format:
Podcast episode
Titles in the series (100)
Epirus Sees Opportunities for Biosimilars Outside U.S.: The regulatory pathway for biosimilars is still a work in progress at the U.S. Food and Drug Administration, but around the world the industry is growing as regulators have resolved issues that remain obstacles in the United States. We spoke to Amit ... by The Bio Report